 
|
Select highlights of recent findings in
neuroendocrine cancer treatment and research presented monthly
and which may include clinical trial results, research findings,
cancer treatment studies and those addressing other issues which
are of interest.
- These presentations are NOT meant to be
taken as recommendations in any manner, but rather are offered
to help provide a sense of the growing edge of cancer research
as pertaining to neuroendocrine treatment, diagnosis and care.
And also to give attention to some of the more current interesting,
unusual or even offbeat studies. Please read the Pancreatica
Disclaimer.
-
-
- Chromogranin A-Biological Function
and Clinical Utility in Neuro Endocrine Tumor Disease
Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd
M.
Ann Surg Oncol. 2010 Mar 9. [Epub ahead of print]PMID: 20217257
[Link to Abstract]
-
-
- Salvage Therapy with (177)Lu-Octreotate
in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine
Tumors
van Essen M, Krenning EP, Kam BL, de Herder WW, Feelders RA,
Kwekkeboom DJ.
J Nucl Med. 2010 Mar;51(3):383-90. Epub 2010 Feb 11.PMID: 20150247
[Link to
Abstract]
-
-
- 90Y-Edotreotide for Metastatic Carcinoid
Refractory to Octreotide
Bushnell DL Jr, O'Dorisio TM, O'Dorisio
MS, Menda Y, Hicks RJ, Van Cutsem E, Baulieu JL, Borson-Chazot
F, Anthony L, Benson AB, Oberg K, Grossman AB, Connolly M, Bouterfa
H, Li Y, Kacena KA, Lafrance N, Pauwels SA.
J Clin Oncol. 2010 Mar 1. [Epub ahead of print]PMID: 20194865
[Link to
Abstract]
-
-
- 177Lu-[DOTA0,Tyr3] Octreotate Therapy
in Patients with Disseminated Neuroendocrine Tumors: Analysis
of Dosimetry with Impact on Future Therapeutic Strategy
Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M,
Ohlsson T, Wingårdh K, Strand SE, Tennvall J.
Cancer. 2010 Feb 15;116(4 Suppl):1084-92.PMID: 20127957
[Link to
Abstract]
-
Treatment with Tandem [90Y]DOTA-TATE and [177Lu] DOTA-TATE
of Neuroendocrine Tumors Refractory to Conventional Therapy:
Preliminary Results
Seregni E, Maccauro M, Coliva A, Castellani MR, Bajetta E, Aliberti
G, Vellani C, Chiesa C, Martinetti A, Bogni A, Bombardieri E.
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):84-91.PMID: 20168290
[Link to
Abstract]
-
-
- Efficacy of using a Standard Activity
of (131)I-MIBG Therapy in Patients with Disseminated Neuroendocrine
Tumours
Navalkissoor S, Alhashimi DM, Quigley AM, Caplin ME, Buscombe
JR.
Eur J Nucl Med Mol Imaging. 2009 Dec 17. [Epub ahead of print]PMID:
20016892
[Link to
Abstract]
-
-
- Neoadjuvant Peptide Receptor Radionuclide
Therapy for an Inoperable Neuroendocrine Pancreatic Tumor
Kaemmerer D, Prasad V, Daffner W, Hörsch D, Klöppel
G, Hommann M, Baum RP.
World J Gastroenterol. 2009 Dec 14;15(46):5867-70.PMID: 19998512
[Link to
Abstract]
-
-
- A Successful Two-Stage Treatment with
CDDP and CPT-11 for Pancreatic Neuroendocrine Carcinoma with
Liver Metastasis
Nomura S, Togawa A, Kaiho T, Shinmura K, Yanagisawa S, Okamoto
R, Nishimura M, Tsuchiya S, Miyazaki M.
Gan To Kagaku Ryoho. 2009 Nov;36(11):1897-900. Japanese. PMID:
19920396
[Link to
Abstract]
-
-
- Refractory Neuroendocrine Tumor-Response
to Liposomal Doxorubicin and Capecitabine
Masi G, Fornaro L, Cupini S, Loupakis F, Vasile E, Baldi GG,
Stasi I, Salvatore L, Falcone A.
Nat Rev Clin Oncol. 2009 Nov;6(11):670-4.PMID: 19861994
[Link to
Abstract]
-
-
- Combined Liver Surgery and RFA for
Patients with Gastroenteropancreatic Endocrine Tumors Presenting
with More Than 15 Metastases to the Liver
Elias D, Goéré D,
Leroux G, Dromain C, Leboulleux S, de Baere T, Ducreux
M, Baudin E.
Eur J Surg Oncol. 2009 Oct;35(10):1092-7. Epub 2009 May 21.PMID:
19464140
[Link to
Abstract]
-
-
- High-Dose Octreotide Acetate for Management
of Gastroenteropancreatic Neuroendocrine Tumors
- Chadha MK, Lombardo J, Mashtare T, Wilding
GE, Litwin A, Raczyk C, Gibbs JF, Kuvshinoff B, Javle MM, Iyer
RV.
Anticancer Res. 2009 Oct;29(10):4127-30.PMID: 19846960
[Link to
Abstract]
-
-
- High-Administered Activity In-111 Octreotide
Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for
Treatment of Neuroendocrine Tumors: Preliminary Experience
Kong G, Johnston V, Ramdave S,
Lau E, Rischin D, Hicks RJ.
Cancer Biother Radiopharm. 2009 Oct;24(5):527-33.PMID: 19877882
[Link to
Abstract]
-
-
- Pancreatic Islet Cell Carcinoma Presenting
with Concurrent Cushing's and Zollinger-Ellison Syndromes: Case
Series and Literature Review
Said R, O'reilly EM, Blumgart L,
Shia J, Abou-Alfa GK.
Eur J Gastroenterol Hepatol. 2009 Sep 18. [Epub]. PMID: 19770666
- [Link
to Abstract]
- Detection of Unknown Primary Neuroendocrine
Tumours (CUP-NET) using (68)Ga-DOTA-NOC Receptor PET/CT
Prasad V, Ambrosini V, Hommann
M, Hoersch D, Fanti S, Baum RP.
Eur J Nucl Med Mol Imaging. 2009 Jul 18. [Epub]. PMID: 19618183
[Link to
Abstract]
- Successful Control of Intractable Hypoglycemia
Using Rapamycin in an 86-year old man with a Pancreatic Insulin-Secreting
Islet Cell Tumor and Metastases.
Bourcier ME, Sherrod A, Diguardo M, Vinik AI.
J Clin Endocrinol Metab. 2009 Jun 30. [Epub] PMID: 19567519
- [Link to Abstract]
-
- Staged Surgery with Neoadjuvant (90)Y-DOTATOC
Therapy for Down-Sizing Synchronous Bilobular Hepatic Metastases
from a Neuroendocrine Pancreatic Tumor.
Stoeltzing O, Loss M, Huber E, Gross V, Eilles C, Mueller-Brand
J, Schlitt HJ.
Langenbecks Arch Surg. 2009 Jun 9. [Epub] PMID: 19506898
[Link
to Abstract]
-
-
- Prolonged Survival After Hepatic Artery
Embolization in Patients with Midgut Carcinoid Syndrome.
Swärd C, Johanson V, Nieveen van Dijkum E, Jansson S, Nilsson
O, Wängberg B, Ahlman H, Kölby L.
Br J Surg. 2009 May;96(5):517-21. PMID: 19358175
- [Link to Abstract]
-
-
- Laparoscopic Surgery for Pancreatic
Insulinomas: A Single-Institution Experience of 29 Cases.
Luo Y, Liu R, Hu MG, Mu YM, An LC, Huang ZQ. J Gastrointest Surg.
2009
May;13(5):945-50. PMID: 19224293
- [Link to Abstract]
-
-
- Liver Resection Versus Other Treatments
for Neuroendocrine Tumours in Patients with Resectable Liver
Metastases.
Gurusamy KS, Ramamoorthy R, Sharma D, Davidson BR.
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007060. PMID: 19370671
[Link
to Abstract]
-
-
- Development of the Norfolk Quality
of Life Tool for Assessing Patients with Neuroendocrine Tumors.
Vinik E, Carlton CA, Silva MP, Vinik AI.
Pancreas. 2009 Apr;38(3):e87-95. PMID: 19276865
[Link
to Abstract]
-
-
- Radiotherapy for Pancreatic Neuroendocrine
Tumors.
Contessa JN, Griffith KA, Wolff E, Ensminger W, Zalupski M, Lawrence
TS, Ben-Josef E.
Int J Radiat Oncol Biol Phys. 2009 Mar 25 [Epub]. PMID: 19327905
[Link
to Abstract]
-
-
- A Rare Surgical Case of Multiple Liver
Resections for Recurrent Liver Metastases from Pancreatic Gastrinoma:
Liver and Vena Cava Resection.
Pachera S, Yokoyama Y, Nishio H, Oda K, Ebata T, Igami T, Abe
T, Shingu Y, Nagino M.
J Hepatobiliary Pancreat Surg. 2009 Mar 10 [Epub]. PMID: 19267257
- [Link to Abstract]
-
-
- Management of the Primary Tumor in
Patients with Metastatic Pancreatic Neuroendocrine Tumor: A Contemporary
Single-Institution Review.
Bruzoni M, Parikh P, Celis R, Are C, Ly QP, Meza JL, Sasson AR.
Am J Surg. 2009 Mar;197(3):376-81. PMID: 19245918
[Link
to Abstract]
-
- Reclassification of Neuroendocrine
Tumors Improves the Separation of Carcinoids and the Prediction
of Survival.
Skov BG, Krasnik M, Lantuejoul
S, Skov T, Brambilla E.
J Thorac Oncol. 2008 Dec;3(12):1410-5. PMID: 19057265
[Link
to Abstract]
-
-
- Combination Therapy with Histone Deacetylase
Inhibitors and Lithium Chloride: A Novel Treatment for Carcinoid
Tumors.
Adler JT, Hottinger DG, Kunnimalaiyaan
M, Chen H.
Ann Surg Oncol. 2008 Nov 22. [Epub]. PMID: 19030935
[Link
to Abstract]
-
-
- Intraoperative Hand Held Gamma Probe
Detection of a Recurrent Nonfunctional Neuroendocrine Tumor.
Van Haren RM, Fitzgerald TL.
JOP. 2008 Nov 3;9(6):704-7. PMID: 18981551
[Link
to Abstract]
-
-
- Laparoscopic Enucleation of a Nonfunctioning
Neuroendocrine Tumor of the Pancreas.
Kang CM, Lee KG, Pyo JY, Lee SW,
Kim KS, Choi JS, Lee WJ, Kim BR.
Yonsei Med J. 2008 Oct 31;49(5):864-8. PMID: 18972611
[Link
to Abstract]
-
-
- Surgical Approach and Perioperative
Complications Determine Short-Term Outcomes in Patients with
Insulinoma: Results of a Bi-Institutional Study.
Roland CL, Lo CY, Miller BS, Holt
S, Nwariaku FE.
- Ann Surg Oncol. 2008 Sep 30. [Epub] PMID:
18825460
[Link
to Abstract]
-
-
- Clinical Applications of 68Ga-DOTANOC
in Neuroendocrine Tumours.
Lopci E, Nanni C, Rampin L, Rubello
D, Fanti S.
- Minerva Endocrinol. 2008 Sep;33(3):277-81.
PMID: 18846030
[Link
to Abstract]
-
-
- Risk Factors Associated with Neuroendocrine
Tumors: A U.S.-Based Case-Control Study.
Hassan MM, Phan A, Li D, Dagohoy
CG, Leary C, Yao JC.
Int J Cancer. 2008 Aug 15;123(4):867-73. PMID: 18491401
[Link
to Abstract]
-
-
- Radioembolization with Selective Internal
radiation Microspheres for Neuroendocrine Liver Metastases.
King J, Quinn R, Glenn DM, Janssen
J, Tong D, Liaw W, Morris DL.
Cancer. 2008 Jul 10. PMID: 18618495
[Link
to Abstract]
-
-
- Activity of Sunitinib in Patients with
Advanced Neuroendocrine Tumors.
Kulke MH, Lenz HJ, Meropol NJ,
Posey J, Ryan DP, Picus J, Bergsland E, Stuart K, Tye L, Huang
X, Li JZ, Baum CM, Fuchs CS.
J Clin Oncol. 2008 Jul 10;26(20):3403-10. PMID: 18612155
[Link
to Abstract]
-
-
- Prognostic Factors of Long-Term Outcome
in Gastroenteropancreatic Neuroendocrine Tumours.
Pape UF, Berndt U, Mueller-Nordhorn
J, Boehmig M, Roll S, Koch M, Willich S, Wiedenmann B.
Endocr Relat Cancer. 2008 Jul 4. PMID: 18603570
[Link
to Abstract]
-
-
- Clinical Value of Monitoring Plasma
Octreotide Levels During Chronic Octreotide Long-Acting Repeatable
Therapy in Carcinoid Patients.
Woltering EA, Salvo VA, O'Dorisio
TM, Lyons J 3rd, Li G, Zhou Y, Seward JR, Go VL, Vinik AI, Mamikunian
P, Mamikunian G.
Pancreas. 2008 Jul;37(1):94-100. PMID: 18580450
[Link
to Abstract]
-
-
- Selective Hepatic arterial Infusion
of In-111-DTPA-Phe(1)-Octreotide in Neuroendocrine Liver Metastases.
Limouris GS, Chatziioannou A, Kontogeorgakos D, Mourikis D, Lyra
M, Dimitriou P, Stavraka A, Gouliamos A, Vlahos L.
Eur J Nucl Med Mol Imaging. 2008 Jun 7. [Epub ahead of print]
PMID: 18536916
[Link
to Abstract]
-
-
- Radioembolization for Unresectable
Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres:
Early Results in 148 Patients.
Kennedy AS, Dezarn WA, McNeillie P, Coldwell D, Nutting C, Carter
D, Murthy R, Rose S, Warner RR, Liu D, Palmedo H, Overton C,
Jones B, Salem R.
Am J Clin Oncol. 2008 Jun;31(3):271-9. PMID: 18525307
[Link
to Abstract]
-
-
- Risk Factors Associated with Neuroendocrine
Tumors: A U.S.-Based Case-Control Study.
Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC.
Int J Cancer. 2008 May 19. [Epub]PMID: 18491401
[Link
to Abstract]
-
-
- Radiolabeled DOTATOC in Patients with
Advanced Paraganglioma and Pheochromocytoma.
Forrer F, Riedweg I, Maecke HR, Mueller-Brand J.
Q J Nucl Med Mol Imaging. 2008 May 16. [Epub]PMID: 18480742
[Link
to Abstract]
-
-
- Primary Tumour Resection in Metastatic
Nonfunctioning Pancreatic Endocrine Carcinomas.
Bettini R, Mantovani W, Boninsegna L, Crippa S, Capelli P, Bassi
C, Scarpa A, Pederzoli P, Falconi M.
Dig Liver Dis. 2008 May 5. [Epub] PMID: 18463008
[Link
to Abstract]
-
-
- Treatment with the Radiolabeled Somatostatin
Analog [177 Lu-DOTA 0,Tyr3]Octreotate: Toxicity, Efficacy, and
Survival.
Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen
M, Kooij PP, Feelders RA, van Aken MO, Krenning EP.
J Clin Oncol. 2008 May 1;26(13):2124-30. PMID: 18445841
[Link
to Abstract]
-
-
- Surgery and Radiofrequency Ablation
for Treatment of Liver Metastases from Midgut and Foregut Carcinoids
and Endocrine Pancreatic Tumors.
Eriksson J, Stålberg P, Nilsson A, Krause J, Lundberg C,
Skogseid B, Granberg D, Eriksson B, Akerström G, Hellman
P.
World J Surg. 2008 May;32(5):930-8. PMID: 18324347
[Link
to Abstract]
-
-
- Comparison Between (68)Ga-DOTA-NOC
and (18)F-DOPA PET for the Detection of Gastro-Entero-Pancreatic
and Lung Neuro-Endocrine Tumours.
Ambrosini V, Tomassetti P, Castellucci P, Campana D, Montini
G, Rubello D, Nanni C, Rizzello A, Franchi R, Fanti S.
Eur J Nucl Med Mol Imaging. 2008 Apr 17. [Epub]PMID: 18418596
[Link
to Abstract]
-
-
- Requiem for the Term 'Carcinoid Tumour'
in the Gastrointestinal Tract?
Chetty R.
Can J Gastroenterol. 2008 Apr;22(4):357-8. PMID: 18414708
[Link
to Abstract]
-
-
- Improved Staging of Patients with Carcinoid
and Islet Cell Tumors with 18F-Dihydroxy-Phenyl-Alanine and 11C-5-Hydroxy-Tryptophan
Positron Emission Tomography.
http://www.ncbi.nlm.nih.gov/pubmed/18349401
J Clin Oncol. 2008 Mar 20;26(9):1489-95. PMID: 18349401
[Link
to Abstract]
-
-
- Pancreatic Cystic Neuroendocrine Tumors:
Preoperative Diagnosis with Endoscopic Ultrasound and Fine-Needle
Immunocytology.
Baker MS, Knuth JL, Dewitt J, Leblanc J, Cramer H, Howard TJ,
Schmidt CM, Lillemoe KD, Pitt HA.
J Gastrointest Surg. 2008 Mar;12(3):450-6. PMID: 18157720
[Link
to Abstract]
-
-
- 6-L-18F-Fluorodihydroxyphenylalanine
PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical
Applications.
Jager PL, Chirakal R, Marriott CJ, Brouwers AH, Koopmans KP,
Gulenchyn KY.
J Nucl Med. 2008 Apr;49(4):573-86. 2008 Mar 14. [Epub] PMID:
18344441
[Link
to Abstract]
-
-
- Targeting Vascular Endothelial Growth
Factor in Advanced Carcinoid Tumor: A Random Assignment Phase
II Study of Depot Octreotide with Bevacizumab and Pegylated Interferon
Alpha-2b.
Yao JC, Phan A, Hoff PM, Chen HX, Charnsangavej C, Yeung SC,
Hess K, Ng C, Abbruzzese JL, Ajani JA.
J Clin Oncol. 2008 Mar 10;26(8):1316-23. PMID: 18323556
[Link
to Abstract]
-
-
- Prognostic Score Predicting Survival
after Resection of Pancreatic Neuroendocrine Tumors: Analysis
of 3851 Patients.
Bilimoria KY, Talamonti MS, Tomlinson JS, Stewart AK, Winchester
DP, Ko CY, Bentrem DJ.
Ann Surg. 2008 Mar;247(3):490-500. PMID: 18376195
[Link
to Abstract]
-
-
- Evaluation of Unusual Neuroendocrine
Tumours by Means of (68)Ga-DOTA-NOC PET.
Fanti S, Ambrosini V, Tomassetti P, Castellucci P, Montini G,
Allegri V, Grassetto G, Rubello D, Nanni C, Franchi R.
Biomed Pharmacother. 2008 Mar 3. [Epub] PMID: 18358680
[Link
to Abstract]
-
-
- Antitumor Activity of Rapamycin and
Octreotide as Single Agents or in Combination in Neuroendocrine
Tumors.
Moreno A, Akcakanat A, Munsell MF, Soni A, Yao JC, Meric-Bernstam
F.
Endocr Relat Cancer. 2008 Mar;15(1):257-66. PMID: 18310292
[Link
to Abstract]
-
-
- Complete Response of CNS-Involved Olfactory
Neuroendocrine Tumor using Multimodal Therapy.
Ahuja G, Cuellar S, Choudhry I, Setty S, Yao M, Villano JL.
Onkologie. 2008 Mar;31(3):119-21. PMID: 18322415
[Link
to Abstract]
- Assessment of the Efficacy and Toxicity
of (131)I-Metaiodobenzylguanidine Therapy for Metastatic Neuroendocrine
Tumours.
Nwosu AC, Jones L, Vora J, Poston
GJ, Vinjamuri S, Pritchard DM.
- Br J Cancer. 2008 Feb 19. PMID: 18283308
[Link
to Abstract]
-
-
- Treatment with Combined Streptozotocin
and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic
Tumors
Fjällskog ML, Janson ET, Falkmer
UG, Vatn MH, Oberg KE, Eriksson BK.
- Neuroendocrinology. 2008 Feb 18. PMID:
18285678
[Link
to Abstract]
-
-
- Is Laparoscopic Resection Adequate
in Patients with Neuroendocrine Pancreatic Tumors?
Fernández-Cruz L, Blanco
L, Cosa R, Rendón H.
World J Surg. 2008 Feb 11. PMID: 18264824
[Link
to Abstract]
-
-
- Islet 1 (Isl1) Expression is a Reliable
Marker for Pancreatic Endocrine Tumors and Their Metastases
Schmitt AM, Riniker F, Anlauf M,
Schmid S, Soltermann A, Moch H, Heitz PU, Klöppel G, Komminoth
P, Perren A.
Am J Surg Pathol. 2008 Feb 5. PMID: 18300808
[Link
to Abstract]
-
-
- Transcatheter Arterial Chemoembolization
(TACE) Using Degradable Starch Microspheres (DSM) (DSM-TACE)
for Primary and Metastatic Liver Neuroendocrine Tumors from Gastrointestinal
Neuroendocrine Tumors
Fujisaki T, Ikari T, Kamei A, Takano
K, Kuraoka K, Yoshimoto K, Hirasawa T, Asahara S.
- Nippon Shokakibyo Gakkai Zasshi. 2008
Feb;105(2):206-13. PMID: 18250591
[Link
to Abstract]
-
-
- Prognostic Factors at Diagnosis and
Value of WHO Classification in a Mono-Institutional Series of
180 Non-Functioning Pancreatic Endocrine Tumours
Bettini R, Boninsegna L, Mantovani
W, Capelli P, Bassi C, Pederzoli P, Delle Fave GF, Panzuto F,
Scarpa A, Falconi M.
- Ann Oncol. 2008 Jan 21. PMID: 18209014
[Link
to Abstract]
-
-
- Report on Short-Term Side Effects of
Treatments with (177)Lu-Octreotate in Combination with Capecitabine
in Seven Patients with Gastroenteropancreatic Neuroendocrine
Tumours
van Essen M, Krenning EP, Kam BL,
de Herder WW, van Aken MO, Kwekkeboom DJ.
- Eur J Nucl Med Mol Imaging. 2008 Jan 11.
PMID: 18188559
[Link
to Abstract]
-
-
- Laparoscopic vs Open Resection of Pancreatic
Endocrine Neoplasms: Single Institution's Experience over 14
Years
Gumbs AA, Grès P, Madureira
F, Gayet B.
- Langenbecks Arch Surg. 2008 Jan 10. PMID:
18196267
[Link
to Abstract]
-
-
- Results Following Surgical Resection
for Malignant Pancreatic Neuroendocrine Tumours. A Single Institutional
Experience
Bonney GK, Gomez D, Rahman SH,
Verbeke CS, Prasad KR, Toogood GJ, Lodge JP, Menon KV.
- JOP. 2008 Jan 8;9(1):19-25. PMID: 18182738
[Link
to Abstract]
-
-
- Functional MRI Evaluation of Tumor
Response in Patients with Neuroendocrine Hepatic Metastasis Treated
with Transcatheter Arterial Chemoembolization.
Liapi E, Geschwind JF, Vossen JA,
Buijs M, Georgiades CS, Bluemke DA, Kamel IR.
- AJR Am J Roentgenol. 2008 Jan;190(1):67-73.
PMID: 18094295
[Link
to Abstract]
-
-
- Thymic Carcinoid Responds to Neoadjuvant
Therapy with Sunitinib and Octreotide: A Case Report.
Dham A, Truskinovsky AM, Dudek
AZ.
- J Thorac Oncol. 2008 Jan;3(1):94-7. PMID:
18166847
[Link
to Abstract]
-
-
- Improved Contemporary Surgical Management
of Insulinomas: A 25-Year Experience at the Massachusetts General
Hospital.
Nikfarjam M, Warshaw AL, Axelrod
L, Deshpande V, Thayer SP, Ferrone CR, Fernández-del Castillo
C.
- Ann Surg. 2008 Jan;247(1):165-72. PMID:
18156937
[Link
to Abstract]
-
-
- Pancreatic Neuroendocrine Tumours.
Alexakis N, Neoptolemos JP.
Best Pract Res Clin Gastroenterol. 2008;22(1):183-205. PMID:
18206821
[Link to Abstract]
-
-
- Diagnostic Value of CDX-2 and TTF-1
Expressions in Separating Metastatic Neuroendocrine Neoplasms
of Unknown Origin.
Lin X, Saad RS, Luckasevic TM,
Silverman JF, Liu Y.
Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):407-14. PMID:
18091383
[Link to Abstract]
-
-
- Use of Octreotide for the Prevention
of Pancreatic Fistula after Elective Pancreatic Surgery: A Systematic
Review and Meta-Analysis.
Alghamdi AA, Jawas AM, Hart RS.
Can J Surg. 2007 Dec;50(6):459-66. Review. PMID: 18053374
[Link
to Abstract]
-
-
- Laparoscopic Enucleation of Insulinomas.
Sweet MP, Izumisato Y, Way LW,
Clark OH, Masharani U, Duh QY.
Arch Surg. 2007 Dec;142(12):1202-4; discussion 1205. PMID: 18086988
[Link
to Abstract]
-
-
- Strategy for the Surgical Management
of Insulinomas: Analysis of 52 Cases.
Liu H, Peng C, Zhang S, Wu Y, Fang
H, Sheng H, Peng S.
- Dig Surg. 2007;24(6):463-70. Epub 2007
Nov 29. PMID: 18057893
[Link to Abstract]
-
-
- Clinicopathologic Features and Treatment
Trends of Pancreatic Neuroendocrine Tumors: Analysis of 9,821
Patients.
Bilimoria KY, Tomlinson JS, Merkow
RP, Stewart AK, Ko CY, Talamonti MS, Bentrem DJ.
J Gastrointest Surg. 2007 Nov;11(11):1460-7; discussion 1467-9.
Epub 2007 Sep 11. PMID: 17846854
[Link to Abstract]
-
-
- Diagnosis and Treatment of Gastric
Neuroendocrine Tumours.
Plöckinger U.
- Wien Klin Wochenschr. 2007 Nov;119(19-20):570-572.
PMID: 17985089
[Link to Abstract]
-
-
- Diagnosis and Treatment of Gastrinoma
in the Era of Proton Pump Inhibitors.
Banasch M, Schmitz F.
- Wien Klin Wochenschr. 2007 Nov;119(19-20):573-578.
PMID: 17985090
[Link to Abstract]
-
-
- Management of Sporadic and Multiple
Endocrine Neoplasia Type 1 Gastrinomas.
Fendrich V, Langer P, Waldmann
J, Bartsch DK, Rothmund M.
Br J Surg. 2007 Nov;94(11):1331-41. PMID: 17939142
[Link to Abstract]
-
-
- Type 1 and 2 Gastric Carcinoid Tumors:
Long-Term Follow-up of the Efficacy of Treatment with a Slow-Release
Somatostatin Analogue.
Manfredi S, Pagenault M, de Lajarte-Thirouard
AS, Bretagne JF.
- Eur J Gastroenterol Hepatol. 2007 Nov;19(11):1021-5.
PMID: 18049175
[Link to Abstract]
-
-
- The Role of Somatostatin Analogues
in the Treatment of Neuroendocrine Tumours.
Grozinsky-Glasberg S, Grossman
AB, Korbonits M.
- Mol Cell Endocrinol. 2007 Oct 13. PMID:
18037561
[Link to Abstract]
-
-
- Embolization of an Insulinoma of the
Pancreas with Trisacryl Gelatin Microspheres as Definitive Treatment.
Rott G, Biggemann M, Pfohl M.
- Cardiovasc Intervent Radiol. Epub 2007
Oct 6. PMID: 17922161
[Link to Abstract]
-
-
- Diagnosis and Surgical Treatment of
Pancreatic Endocrine Tumors in 36 Patients: A Single-Center Report
Liu H, Zhang SZ, Wu YL, Fang HQ,
Li JT, Sheng HW, Wang Y.
Chin Med J (Engl). 2007 Sep 5;120(17):1487-90. PMID: 17908455
[Link to Abstract]
-
-
|
